Barbasch Avi MD - NY New York, New York City 10028

Barbasch Avi MD entered the industry of Internal Medicine Practitioners in 1982 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Practitioners. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Practitioners. The business provides service to the B2C market.

To acquire more information, please contact Avi Barbasch by calling (212) 860-3292 during business hours. You can also write to the business’ Single Location at 1050 Park Avenue, New York City, New York NY 10028. You can also visit the company’s website at cancerrx.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: Barbasch Avi MD
Representative: Avi Barbasch
Place of Business: 1050 Park Avenue, New York City, NY 10028
Contact Number: (212) 860-3292
Website: cancerrx.org
Type of Service: Internal Medicine Practitioners
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1982
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Barbasch Avi MD is a company operating from New York, New York providing professional Internal Medicine Practitioners and relevant B2C variables. It was founded in 1982 and registered with the SIC code 8011 as Internal Medicine Practitioners, and with the NAICS code 6211110 as Internal Medicine Practitioners.

With a current employee count of 1 to 4, Barbasch Avi MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Avi Barbasch at (212) 860-3292 for related queries, or to locate its Single Location using the coordinates 40.780682,-73.956917.

The Single Location can also be found at the street address 1050 Park Avenue in New York City, New York 10028 and can be engaged online through the company website at cancerrx.org, the company Twitter , and Facebook page .